New Maintenance Option Approved for Asthma

(MedPage Today) -- The FDA approved budesonide/glycopyrrolate/formoterol fumarate (Breztri Aerosphere) in a single inhaler as maintenance therapy for asthma in adults and children 12 years and up, AstraZeneca announced on Tuesday. Approval of...
Source
MedPage Today
Opens original article in a new tab



